The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $130,950 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Regents of the University of Idaho, doing business as the University of Idaho. The grant supports a 2-year research project to understand the regulatory mechanisms governing the developmental cycle of chlamydial bacteria, which cause a range of infectious diseases in humans.
The research aims to dissect the gene expression patterns and functions of the three distinct cell forms (elementary body, reticulate body, and intermediate body) that characterize the chlamydial developmental cycle. Specific objectives include developing a CRISPR interference screen to assess the role of essential genes in regulating cell type transitions, and investigating the cell type-specific expression of the bacteria's Type III secretion system translocons, which facilitate interactions with host cells. This enhanced understanding of the chlamydial developmental cycle is expected to enable more effective targeting of therapeutic interventions and dissemination strategies.
Generated 2/25/25, 2:51 AM